Select Funding Opportunities
Click here to visit the NCI grant site.
Use your device's search function to find a specific disease or funding source.
Funding
The Vera and Joseph Dresner Foundation
MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
Time-Sensitive Obesity Policy and Program Evaluation (R01)
This FOA establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors and/or weight outcomes in an effort to prevent or reduce obesity.
Application Deadline: September 22, 2021
Charles H. Hood Foundation: Child Health Research Awards Program
This award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding.
Application Deadline: September 22, 2021
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54)
This RFA aims to facilitate institutions in building a community of scientists by recruiting and supporting a cohort of early-career faculty who have demonstrated a commitment to diversity and inclusive excellence.
Application Deadline: September 24, 2021
NCCN/Lilly RFP to Optimize Biomarker Driven Therapy in Lung and Thyroid Cancers
The intent of this RFP is to encourage NCCN Member Institutions to submit proposals describing concepts and ideas for developing, implementing and evaluating healthcare provider performance and/or healthcare quality improvement initiatives to improve patient care and outcomes in relation to molecular profiling and targeted therapies for lung and thyroid cancers.
Application Deadline: September 28, 2021
Cancer Research Institute Irvington Postdoctoral Fellowship Program
Supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology. Proposals should include studies that directly impact our understanding of the immune system’s role in cancer.
Application Deadline: October 1, 2021
Technology Development for Single-Molecule Protein Sequencing (R01)
This FOA solicits grant applications to catalyze major advances in single-molecule protein sequencing and single cell proteome analysis through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.
Application Deadline: October 1, 2021
Rally Foundation Collaborative Pediatric Cancer Research Awards Program
Rally helps fund the most promising research initiatives, and invests in projects and innovative approaches to research which could lead to advanced studies or clinical trials.
Application Deadline: October 1, 2021
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01)
Through this FOA, the NCI invites R01 grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of these modalities in the characterization of therapy response and/or emergence of treatment resistance.
Application Deadline: October 5, 2021
Molecular Imaging of Inflammation in Cancer (R01)
The purpose of this FOA is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo.
Application Deadline: October 5, 2021
Cancer Target Discovery and Development (CTD2) (U01)
Through this FOA, the NCI will support the program Cancer Target Discovery and Development. CTD2 is focused on efforts that advance cancer research by bridging the knowledge gap between the large volumes of comprehensive molecular characterizations of many cancer types and studies of the underlying etiology of cancer development, progression, and/or metastasis.
Application Deadline: October 6, 2021
Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01)
The NCI invites research grant applications for transdisciplinary studies that will enhance our knowledge of the dynamics and underlying mechanisms that link obesity, metabolic dysregulation and increased cancer risk as part of the Metabolic Dysregulation and Cancer Risk Program. Through this FOA, the Metabolic Dysregulation and Cancer Risk Program will focus on metabolic dysregulation as the key process linking obesity with cancer risk.
Application Deadline: October 6, 2021
Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24)
Through this FOA, the NCI will support a Coordinating Center to facilitate coordination across the consortium of multiple individual research project grants for the Metabolic Dysregulation and Cancer Risk Program whose overarching goal is to enhance our knowledge of the dynamics, and underlying mechanisms, that link obesity, metabolic dysregulation, and increased cancer risk.
Application Deadline: October 6, 2021
Melanoma Research Alliance RFPs
The MRA is pleased to announce RFPs for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.
Team Science Award LOI Due: October 6, 2021
Young Investigator Award Checklist Due: November 3, 2021
Pilot Awards Due: November 3, 2021
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54)
The purpose of this FOA is to solicit applications for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54). The overall goal of the CAP-IT Program is to establish an agile and effective network infrastructure to undertake collaborative research focusing on precision cancer prevention and interception, with the overarching goal of discovering molecularly or immunologically targeted agents designed to prevent or intercept the oncogenic process in higher-risk populations.
Application Deadline: October 7, 2021
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24)
The purpose of this FOA is to solicit Applications for the Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24). The overall goal of this FOA and the companion FOA (U54 CAP-IT Specialized Centers, RFA-CA-21-038) is to establish an agile and effective network infrastructure to undertake collaborative research focusing on precision cancer prevention and interception, with the overarching goal of discovering molecularly or immunologically targeted agents designed to prevent or intercept the oncogenic process in higher-risk populations.
Application Deadline: October 7, 2021
NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award
This award supports outstanding PhD and other Research Doctoral candidates to complete their dissertation research training (F99 phase) and transition in a timely manner to mentored, cancer-focused postdoctoral career development research positions (K00 phase).
Letter of Intent Due: October 10, 2021
AACR Anna D. Barker Basic Cancer Research Fellowship
This award supports postdoctoral or clinical research fellows to establish a successful career path in cancer research.
Application Deadline: October 14, 2021
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)
The purpose of this award is to prepare individuals for careers that have a significant impact on the health-related research needs of the nation.
Application Deadline: October 12, 2021
NCI Transition Career Development Award to Promote Diversity (K22)
The purpose of this award is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.
Application Deadline: October 12, 2021
Debbie's Dream Foundation Career Development Award for Gastric Cancer Research
This award supports junior faculty to conduct gastric cancer research and to establish a successful career path in this field.
Application Deadline: October 28, 2021
Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers
The goal of this program is to provide support for a mentored research training experience for individuals with high potential to re-enter or re-integrate into an active research career, after an interruption for family responsibilities or other qualifying circumstances.
First Available Due Date: November 1, 2021
NCI Research Specialist Awards (Laboratory-based Scientist) Award (R50)
This FOA invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists and is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators.
Application Deadline: November 1, 2021
NCI Research Specialist (Core-based Scientist) Award (R50)
This FOA invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists and is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators.
Application Deadline: November 1, 2021
Acquired Resistance to Therapy Network (ARTNet; U54)
The ARTNet FOA is a new funding opportunity that builds upon the Drug Resistance and Sensitivity Network (DRSN, RFA-CA-17-009) to focus study on the mechanistic basis of acquired resistance to cancer therapies and disease recurrence.
Application Deadline: November 1, 2021
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24)
The overarching goal of the ARTNet is to bridge basic, pre-clinical, and translational research along the tumor-tumor microenvironment continuum to inform new strategies that can be better translated to overcome significant challenges in acquired resistance to cancer therapies. The Coordinating Center will assemble the appropriate infrastructure to facilitate and implement the administrative, outreach, collaborative and data management activities of the ARTNet.
Application Deadline: November 1, 2021
Emerging Global Leader Award (K43)
The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country who holds a junior faculty position at an LMIC academic or research institution.
Application Deadline: November 3, 2021
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33)
The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.
Application Deadline: November 15, 2021
Cancer Research Institute Technology Impact Award
These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.
Letter of Intent Due: November 15, 2021
Understanding Oral HPV Infection, Acquisition, and Persistence in People Living with HIV (R01, R21)
The purpose of these FOAs are to solicit research to better understand the epidemiology and biology of oral HPV infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV.
Application Deadline: November 18, 2021
The Hope Foundation for Cancer Research SEED Fund for SWOG Early Exploration and Development 2021
These awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology. $50,000
Application Deadline: December 1, 2021
DKMS Stiftung Leben Spenden (Foundation for Giving Life) - John Hansen Research Grant
Supports up to four international young scientists each year who want to advance the fight against blood cancer with their promising research projects in the field of blood stem cell transplantation and cell therapy.
Application Deadline: December 3, 2021
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01)
The purpose of this FOA is to support and accelerate the integration of evidence-based cancer control interventions for PLWH by leveraging existing HIV treatment and prevention infrastructure.
Application Deadline: December 15, 2021